Industry News:

Innovaro Pharmalicensing

Latest: Watch here for details of new products and services.

About Us: Innovaro Pharmalicensing - Partnering solutions for the life sciences
Our Products: Overview; Partnering Search; Company Profiling; Pay-per-Click New!; Deal Negotiation; PL Intelligence; Reports; Comparison
PL Intelligence: Overview; Industry news; Deals review; Press releases; Articles
Case Studies: See what others think about our service
Newsletter: Partnering update; Key reports; Subscribe
Quick Links: Profile now; Register now; Profiled companies; Featured events; Industry news; PR Newswire; Jobs
Contact Innovaro Pharmalicensing: Send an email; Call us: +44 1904 520460; Request a callback
RSS Feeds: Keep up to date

Innovaro Pharmalicensing
is a division of
Innovaro Europe Ltd

Innovaro Corporation

Industry news

Related news

Latest News

Roche provides update on phase III study of Avastin in men with late stage prostate cancer

FDA Announces New Boxed Warning on Plavix

Genentech Provides Update on Phase III Study of Avastin in Men With Late Stage Prostate Cancer

CML HealthCare Income Fund Reports 2009 Year-End Financial Results

The Results of CSPS II, a Large-scale Clinical Trial of Cilostazol in Preventing Recurrent Strokes, Presented at American Stroke Association's International Stroke Conference on February 26

ARIAD Receives Orphan Drug Designations for Its Investigational pan BCR-ABL Inhibitor, AP24534, in Chronic Myeloid Leukemia

AMAG Pharmaceuticals Announces Fourth Quarter and Year End 2009 Financial Results

GTC PROVIDES UPDATE ON TG20 MONOCLONAL ANTIBODY TARGETING CD20

Vion Receives Response from FDA on Special Protocol Assessment for Onrigin(TM)

Sunesis Poised for Phase 3 Trial of Voreloxin in Acute Myeloid Leukemia After Completing Formal End-of-Phase 2 Meetings With FDA

More news... | RSS Feed...

Most Viewed

Genoptix Announces National Three-Year Agreement With Aetna

Novartis drug Tasigna

GTC PROVIDES UPDATE ON TG20 MONOCLONAL ANTIBODY TARGETING CD20

CML HealthCare Income Fund Announces Release Date for Fiscal 2009 Fourth Quarter Financial Results

ARIAD Receives Orphan Drug Designations for Its Investigational pan BCR-ABL Inhibitor, AP24534, in Chronic Myeloid Leukemia

FDA Clears Haemonetics 510(k) to collect 2RBC from More Female Donors

AMAG Pharmaceuticals Announces Fourth Quarter and Year End 2009 Financial Results

Sunesis Poised for Phase 3 Trial of Voreloxin in Acute Myeloid Leukemia After Completing Formal End-of-Phase 2 Meetings With FDA

CML HealthCare Income Fund Reports 2009 Year-End Financial Results

FDA Approves Rituxan to Treat Chronic Lymphocytic Leukemia

Clients in focus...

Get the Flash Player to see this rotator.

Press releases: Innovaro Pharmalicensing current industry press releases.

Products:	Partnering Search	Pay-per-Click	Company Profiling	PL Intelligence	Reports	Comparision
In-licensing:	Latest records	Industry Sector	Therapeutic Target	Search	Profile your company	Pharma partnering
Out-licensing:	Latest records	Industry Sector	Therapeutic Target	Search	Profile your company	Pharma partnering
Companies:	Profiled companies	Industry Sector	Therapeutic Target	Geographic Location	Search	Add your company
Reports:	Biotechnology	Business Development	Management	Market & Sales	Medical Devices	Pharmaceuticals
Jobs:	Pharmaceutical jobs	Browse jobs	Search for jobs	Create your CV	Employer profiles	Post your jobs
Forums:	Talk to an expert	Industry Gossip	Business Development	What's new	Reports	Services
News:	Deals & Alliances	Development	Financial Results	Financings	Intellectual Property	Regulatory
Events:	Pharma events	Calendar	Organizers	Featured events	Search
Articles:	Business Development	Technologies	Events	Legal and regulatory	Therapeutic
Deals:	Industry Sector	Therapeutic Target	Deals Date	Search	Reports	Press releases
About us:	Our Audience	Case Studies	Newsletter	Careers	FAQ	Contact us

© Copyright 1998-2010 Innovaro Pharmalicensing, a division of Innovaro Europe Ltd All rights reserved. Terms and Conditions | Contact us